9/103 sources · 3 publishersUpdated Nov 12, 14:04 UTC
Wendy's board rejects $1.4 billion takeover offer and adopts poison‑pill defense
Wendy's independent board committee unanimously rejected a $1.4 billion cash offer that valued the company at $7.35 per share, deeming it substantially undervalued. The board implemented a shareholder rights plan (poison pill) that will remain in effect for one year to deter any hostile bid. The rejection coincided with a 37% rally in Wendy's shares over the next 11 trading sessions, bringing the price close to $8.
Why it matters
The board's refusal and the poison‑pill adoption kept the company independent, preserving its turnaround strategy and allowing shareholders to benefit from the recent 37% stock rally.
Key facts
- 1The takeover proposal valued Wendy's at $7.35 per share in cash, amounting to approximately $1.4 billion. finance.yahoo.com
- 2The offer represented a 20% premium over Wendy's closing share price of $6.14 on October 27. foodbusinessmea.com
- 3Wendy's board adopted a shareholder rights plan (poison pill) on November 4 that lasts one year. qz.com
- 4Wendy's reported third‑quarter 2026 net income of $15.1 million, down 66% from the prior year. foodbusinessmea.com
- 5Adjusted EBITDA for Q3 2026 declined 18% to $113.4 million. foodbusinessmea.com
- 6Revenue for Q3 2026 slipped 0.5% to $547 million. foodbusinessmea.com
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.